Hong RX, Xu F, Xia W, Teng YE, et al. Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-The Phase III MECCA Trial. J Clin Oncol 2025 Jan 2:JCO2400938. doi: 10.1200/JCO.24.00938.
PMID: 39746176